Home / Import refusals / F23-9340393-6/40002/1

FDA Import Refusal F23-9340393-6/40002/1 — Eli Lilly Italia SPA

Eli Lilly Italia SPA — FEI 3002806895

The FDA refused shipment F23-9340393-6/40002/1 from Eli Lilly Italia SPA (Italy) on September 3, 2025. The refused product falls under Drugs and Biologics — TIRZEPATIDE (ANTI-DIABETIC). Cited charge: 75 This firm has 5 or more other import refusals on record.

Refusal Details

Date
September 3, 2025
Country
Italy
Product Category
Drugs and Biologics
Product Code
61PCY74 TIRZEPATIDE (ANTI-DIABETIC)
Charges
75

Recent inspections

  • 1258572 (VAI Tue Apr 04 2023 00:00:00 GMT+0000 (Coordinated Universal Time))

Other import refusals

  • AEK-0329280-1/10002/1 (Tue May 05 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • AEK-0316984-3/10002/1 (Thu Apr 16 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 799-5527577-7/10002/1 (Fri Mar 27 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 799-4422794-7/10002/1 (Tue Mar 24 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • AEK-9464097-4/10001/1 (Fri Feb 20 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)

FDA data resources